1 2 4 5 13 32 37 45 67 69 70 71 73 74 76 164

15 13 77 9 Appleby Trust (Cayman) Ltd. Clifton House, 75 Fort Street PO Box 1350 Grand Cayman KY1-1108 Cayman Islands A 10 6-8 19 1906-1907 Appleby Trust (Cayman) Ltd. Clifton House 75 Fort Street PO Box 1350 Grand Cayman KY1-1108 Cayman Islands 2

98 359-361 1 2 183 22 01110 www.kingworld.com.cn 3 2015

713,548 660,323 8.1% (486,771) (504,013) (3.4)% 226,777 156,310 45.1% 51,322 48,667 5.5% 39,387 37,865 4.0% 4.74 6.07 (21.9)% 1.53 1.92 (20.3)% (1) 1.7 1.8 (5.6)% (2) 1.4 1.7 (17.6)% (3) 15.5% 22.4% (30.8)% (1) (2) (3) 100% 4

+ 5 2015

600 1 + + 1 B2B2C 1 + + 2 80 90 6

(Cuturelle) & 2015 HBA 2015 (Fatblaster) 7 2015

3 4 4,419 SAP SAP SAP ERP SAPERP HR SAP ERP 2016 1 ERP 2016 2 PMS SAP 5 55% 500 Sinopharm Healthcare Fund L.P. 3.33% 8

8.6 2289.HK 2,302,000 54,929,000 15% 70 6 9 2015

EMBA 2015 2015 2014 2015 1 2 3 SAP ERP PMS SAP SAP ERP CRM 2016 10

Naris Up Carmex Kneipp 80 4 5 B2B2C 4,500 11 2015

6 ZAKER 12

1. + 2. 13 2015

3. + + B2C 160.6 58.9% 60% 40% + 4. 100 200 2,000 1,200 1,600 14,300 20,000 650 2,000 14

5. 2,900 5,591 8.82% GDP 1,080.92 92.44 12.05% 4.71% 1. 300 321 200,000 4,419 15 2015

299,143,000 41.1% 26,857,000 30.3% 49,644,000 21.9% A A GMP 13,333,000 99.9% 41,905,000 590.5% 31,048,000 24.4% 16

92,775,000 227.0% (BLACKMORES) 1,190,000 BRAINSTRONG DHA (FATBLASTER) (Culturelle) BRAINSTRONG DHA (FATBLASTER) (BLACKMORES) (FUYUNHON) (WIOM) (Culturelle) 2. 17 2015

(Culturelle) (WIOM) BRAINSTRONG DHA (FATBLASTER) (BLACKMORES) (FUYUNHON) 3. Key Account KA KA 38 4. + + 1 18

+ + B2B2C 19 2015

5. 189,366,892 55% Sinopharm Capital Limited 5,000,000 38,900,000 3.33% 54,929,000 15% 70 20

20,000,000 8.6 2289 HK 2,302,000 5,756 6. 7. 21 2015

1. BI ERP SAP ERP SAP HR SAP SAP ERP 2. 22

3. EMBA 23 2015

1. 713,548,000 660,323,000 53,225,000 8.1% (Culturelle) 2. 486,771,000 504,013,000 17,242,000 3.4% 23.7% 31.8% (Culturelle) 3. 22,760,000 28,946,000 6,186,000 21.4% 9,100,000 6,246,000 24

4. 24,276,000 5,941,000 18,335,000 308.6% 5. 101,473,000 87,734,000 13,739,000 15.7% 4,879,000 1,088,000 2,436,000 3,272,000 2,584,000 17,531,000 5,378,000 7. 49,153,000 49,301,000 148,000 0.3% 8. 15,738,000 6,873,000 8,865,000 129.0% 6. 69,273,000 45,890,000 23,383,000 51.0% 3,117,000 11,412,000 4,018,000 9. 51,322,000 48,667,000 2,655,000 5.5% 17,907,000 25 2015

10. 11,935,000 10,802,000 1,133,000 10.5% 23.3% 22.2% 11. 39,387,000 37,865,000 1,522,000 4.0% 2,655,000 1,133,000 1. 287,110,000 417,774,000 130,664,000 69,074,000 102,384,000 131,865,000 225,054,000 62,791,000 122,670,000 2. 79,005,000 70,016,000 8,989,000 3. 15,811,000 5,121,000 10,690,000 6,259,000 3,814,000 4. 159,047,000 186,062,000 27,015,000 40,786,000 26

1. 102,790,000 5,230,000 167,631,000 2. 168,128,000 29,721,000 147,821,000 3. 888,000 144,078,000 1. 167,560,000 228,677,000 2. 15.5% 22.4% 100% 3. 218,133,000 4. 6,259,000 1,973,000 27 2015

4.2% 132,478,000 230,028,000 23,800,000 191,097,000 55% 189,366,892 ( 55% 15% 30% 55% (1) 15% (2) 1. 28

SAP ERP PMS 2. KA KA 30% 29 2015

3. 80 B2B2C 4. 30

954 122 379 34 453 66,547,000 43,500,000 1.53 9,254,000 25.5% EMBA EDP 31 2015

57 20 Business Management Qualification Accreditation Committee 52 20 11 EMBA 49 18 32

50 15 2005 40 16 7 Sanofi-Aventis Burrill & Company 50 25 000607 600976 600422 600572 000650 33 2015

47 20 Victoria University of Technology Going Accounting Services Company 2389 1803 55 23 34

55 30 50 25 57 13 45 17 47 25 012 51 15 35 2015

53 22 53 20 36

A.2.1 A.2.1 37 2015

3.10(1) (2) 3.10A 38

D.3.1 B.1.2(c)(ii) 39 2015

40

4/4 1/1 4/4 1/1 4/4 1/1 2/4 1/1 4/4 1/1 4/4 2/2 2/2 2/2 1/1 4/4 2/2 2/2 2/2 1/1 4/4 2/2 2/2 2/2 1/1 A.6.5 41 2015

976,000 1,200,000 1,274,000 1,566,000 42

3.29 43 2015

6-8 19 1906-1907 kingw@kingworld.com.cn www.kingworld.com.cn 44

10 60 69 163 1.53 9,524,000 25.5% 183 22 183 22 45 2015

13 31 164 3R (Reduce) (Recycle) (Reuse) 46

(1) 15% (2) 241,862,000 206,167,000 134,920,000 4,000,000 15,760,000 20,600,000 94,560,000 47 2015

(a) 10% 600,000,000 30% 60,000,000 10% 9.64% (b) 1% (c) (i) (ii) (iii) (d) 10 (e) 1 (f) (g) 48

1 2 3 4 5 2.54 520,000 520,000 0.08% 2.54 468,000 468,000 0.08% 2.54 468,000 468,000 0.08% 2.54 468,000 468,000 0.08% 2.54 412,000 412,000 0.07% 2.54 412,000 412,000 0.07% 2.54 412,000 412,000 0.07% 2.54 412,000 412,000 0.07% 3,572,000 3,572,000 0.57% 57 2.54 13,236,000 13,236,000 2.13% 5 6 16,808,000 16,808,000 2.70% 2.54 300,000 300,000 0.05% 2.54 6,200,000 6,200,000 0.99% 23,308,000 23,308,000 3.74% 1 2 3 4 49 2015

5 2.45 6 (i) 30,000 (ii) 6,200,000 2.54 27 25% 50

31 73 31 198,281,000 226,804,000 1.53 1.28 1.92 1.51 7,968,000 9,400,000 875,000 1,594,000 13 11,900,000 3,560,000 14 16 51 2015

32 36 3.13 11 12 52

1,142 956 922 3,051 176,400 53 2015

130 148 130 54

(a) XV (i) XV 7 8 (ii) 352 (iii) (I) 1 9,392,000 1.51% 90,000,000 14.46% 297,812,250 47.84% 2 307,204,250 49.35% 90,000,000 14.46% 3 3,800,000 0.61% 4 62,250,000 10.00% 1. 9,392,000 387,812,250 (a) 297,812,250 297,812,250 (b) 90,000,000 90,000,000 55 2015

2. 397,204,250 (a) 90,000,000 90,000,000 (b) 9,392,000 297,812,250 9,392,000 297,812,250 3. 3,800,000 4. Shine Light Investment Fund Legend Times Corporation Limited 93,686,250 40,151,250 133,837,500 2.15 62,250,000 Shine Light Investment Fund Legend Times Corporation Limited 62,250,000 XV 10% Shine Light Investment Fund 95,000 Shine Light Investment Fund 99.89% 62,250,000 XV 56

(II) 4 5 1 2 3 2.54 520,000 520,000 0.08% 2.54 468,000 468,000 0.08% 2.54 468,000 468,000 0.08% 2.54 468,000 468,000 0.08% 2.54 412,000 412,000 0.07% 2.54 412,000 412,000 0.07% 2.54 412,000 412,000 0.07% 2.54 412,000 412,000 0.07% 3,572,000 3,572,000 0.57% 1 2 3 4 5 2.45 57 2015

(III) 100% 100% Shine Light Investment Fund 33.33% XV (i) XV 7 8 (ii) 352 (iii) XV 2 3 58

(b) XV 2 3 336 297,812,250 47.84% 90,000,000 14.46% 1 9,392,000 1.51% 90,000,000 14.46% 297,812,250 47.84% 2 307,204,250 49.35% 90,000,000 14.46% Sinopharm Healthcare Fund L.P. 3 62,187,750 9.99% Sinopharm Capital Limited 4 62,187,750 9.99% Shine Light Investment Fund 5 62,250,000 10.00% Shine Light Fund Management Limited 6 62,250,000 10.00% Hwabao Trust Co. Ltd. 7 62,250,000 10.00% 8 62,250,000 10.00% 9 62,250,000 10.00% Legend Times Corporation Limited 5 62,250,000 10.00% 59 2015

Chief Marine Limited 10 62,250,000 10.00% CDBI Parnters Fund I, L.P. 11 62,250,000 10.00% CDBI Parnters GP, Ltd 12 62,250,000 10.00% Tan Ching 13 62,250,000 10.00% Sun Hill Capital Investments Limited 14 124,437,750 19.99% 15 124,437,750 19.99% 1. 9,392,000 387,812,250 (a) 297,812,250 297,812,250 (b) 90,000,000 90,000,000 2. 397,204,250 (a) 90,000,000 90,000,000 (b) 9,392,000 297,812,250 9,392,000 297,812,250 3. Sinopharm Healthcare Fund L.P. 133,703,662.5 62,187,750 4. Sinopharm Capital Limited Sinopharm Healthcare Fund L.P. 1.91% 60

5. Shine Light Investment Fund Legend Times Corporation Limited 93,686,250 40,151,250 133,837,500 2.15 62,250,000 Legend Times Corporation Limited Shine Light Investment Fund 62,250,000 XV 10% 6. Shine Light Fund Management Limited Shine Light Investment Fund 0.11% 7. Hwabao Trust Co. Ltd. Shine Light Investment Fund 99.89% 1 2 QDII 8. 1 2 QDII 9. 33.33% 10. Chief Marine Limited Legend Times Corporation Limited 100% 11. CDBI Parnters Fund I, L.P. Chief Marine Limited 100% Legend Times Corporation Limited 100% 12. CDBI Parnters GP, Ltd CDBI Parnters Fund I, L.P. Chief Marine Limited Legend Times Corporation Limited 100% 13. Tan Ching CDBI Parnters GP, Ltd 99% CDBI Parnters Fund I, L.P. Chief Marine Limited Legend Times Corporation Limited 100% 14. Sun Hill Capital Investments Limited Sinopharm Capital Limited 100% Sinopharm Healthcare Fund L.P. 1.91% Shine Light Fund Management Limited 100% Shine Light Investment Fund 0.11% 15. Sun Hill Capital Investments Limited 70% Sinopharm Capital Limited 100% Sinopharm Healthcare Fund L.P. 1.91% Shine Light Fund Management Limited 100% Shine Light Investment Fund 0.11% XV 2 3 336 61 2015

Sinopharm Capital Limited 5,000,000 38,900,000 3.89% 9.99% 14A 62

14A 36 14A 36 11 14A 14A 2,449 81,270 33,520 63 2015

51% 49% 40% 51% 49% 40% (i) (ii) (iii) 64

(i) (ii) (iii) (iv) (1) (2) 218,133,000 4.2% 132,478,000 230,028,000 65 2015

18.5% 7.6% 99.6% 78.2% 5% 2(w) 66

69 163 67 2015

P03024 68

4 713,548 660,323 (486,771) (504,013) 226,777 156,310 14 11,900 3,610 6 (1,516) 23,005 (101,473) (87,734) (69,273) (45,890) 19 (17,262) 49,153 49,301 7(a) (15,738) (6,873) 17,907 6,239 7 51,322 48,667 8 (11,935) (10,802) 39,387 37,865 31,205 37,865 8,182 39,387 37,865 10 4.74 6.07 4.74 6.07 76 163 69 2015

39,387 37,865 (2,039) (357) 1,513 (526) (357) 38,861 37,508 29,601 37,508 9,260 38,861 37,508 76 163 70

13 15,811 5,121 14 107,880 92,420 18 62,940 45,033 15 75,000 75,000 17 90,693 19 116,165 20 9,609 478,098 217,574 21 79,005 70,016 22 287,110 417,774 20 86,296 30 4,604 23 14,040 24 84,097 25 132,478 230,028 603,533 801,915 26 159,047 186,062 30 16,362 27 167,560 228,677 28 4,155 7,277 29(a) 17,059 12,868 364,183 434,884 239,350 367,031 717,448 584,605 28 3,326 29(b) 30,182 10,304 30,182 13,630 687,266 570,975 76 163 71 2015

31 53,468 53,468 537,918 517,507 591,386 570,975 95,880 687,266 570,975 76 163 72

31(a)) 31(b)) 31(c)) 31(d)) 31(e)) 31(f)) 31(g)) 31(h)) 31(i)) 53,468 152,700 33,936 29,068 5,003 94,905 (14,040) 215,935 570,975 570,975 31,205 31,205 8,182 39,387 435 (2,039) (1,604) 1,078 (526) 435 (2,039) 31,205 29,601 9,260 38,861 221 (221) 9(b)) (9,400) (9,400) (143) (9,543) 210 210 210 38 86,763 86,763 53,468 152,700 34,157 29,068 5,003 94,905 435 (16,079) 210 237,519 591,386 95,880 687,266 53,468 152,700 32,681 29,068 5,003 (13,683) 198,187 457,424 457,424 37,865 37,865 37,865 (357) (357) (357) (357) 37,865 37,508 37,508 94,905 94,905 94,905 1,255 (1,255) 9(b)) (18,862) (18,862) (18,862) 53,468 152,700 33,936 29,068 5,003 94,905 (14,040) 215,935 570,975 570,975 76 163 73 2015

51,322 48,667 7(c) 3,814 1,724 7(a) 15,738 6,873 6 (4,313) (2,100) 6 (4,033) 7(c) 40 21 7(c) 10 7(c) 145 6 2,634 6 2,573 6 1,814 7(c) 17,262 (17,907) (6,239) 14 (11,900) (3,610) 21 1,102 479 (31,201) 167,631 (44,618) (106,907) 31,692 118,402 2,311 (15,612) (7,541) 102,790 (5,230) 76 163 74

(6,259) (1,973) 2 (35,491) (16,753) (147,821) 29,850 (29,850) 4,033 4,313 2,100 (168,128) (29,721) 84,097 (65,994) 167,560 437,081 (228,677) (306,782) 105,448 (14,468) (6,813) (9,400) (18,862) (888) 144,078 (66,226) 109,127 200,178 91,416 (1,474) (365) 25 132,478 200,178 76 163 75 2015

1. 22 (i) (ii) 2. a) 3 76

2. b 2(f) 2(e) 2(aa) 33 77 2015

2. c 2(j)) 78

2. d) 2(j)) 79 2015

2. e) 2(s)(v) (iv) 2(j)) 2(s)(v) 80

2. f) 2(h)) 2(s)(ii) 2(h)) 2(h) g) 2(j)(ii)) 5 5 10 10 5 (i) (ii) 81 2015

2. g) h 82

2. h i) 2(f)) ii) i) 83 2015

2. j) i) 2(d)) 2(j)(ii) 2(j)(ii) 84

2. j) i) 85 2015

2. j) ii 86

2. j) ii iii 34 2(j)(i) (ii)) k) 2(j)(i)) l) 87 2015

2. m) n) o) 88

2. o) 2(f) 89 2015

2. p) q) r) 90

2. r) s) i ii) iii) iv) v) 91 2015

2. t) u) 92

2. v) i) 12 19 2 5 93 2015

2. v) i) 39 ii) 94

2. v) ii) w) i) ii) iii) 95 2015

2. w) iv 39 96

2. x a) i) ii) iii) b) i) ii iii iv) v) vi) (a) vii) (a)(i) viii 97 2015

2. y) 8 5 z) aa) 39 2(s) 98

2. aa) 39 3. 19 19 24 99 2015

4. 444,023 611,200 128,389 49,123 141,136 713,548 660,323 5. 1. 2. 100

5. a) EBITDA EBITDA EBITDA 101 2015

5. a) 99,815 28,250 544,670 708,378 141,136 785,621 736,628 489 1,355 302 791 1,355 100,304 29,605 544,972 708,378 141,136 786,412 737,983 EBITDA 24,688 2,248 41,231 40,162 34,822 100,741 42,410 5 387 1,752 682 31 1,788 1,069 1 8,146 6,813 8,147 6,813 690 695 1,109 1,029 19,277 21,076 1,724 178,598 65,229 569,161 853,814 278,054 1,025,813 919,043 62,940 45,033 62,940 45,033 90,693 2,567 1,973 153,542 246,802 1,973 32,685 38,792 117,677 414,120 52,817 203,179 452,912 102

5. b) 786,412 737,983 (791) (1,355) (72,073) (76,305) 4 713,548 660,323 100,741 42,410 (1,516) 23,005 (21,076) (1,724) (15,738) (6,873) (11,089) (8,151) 51,322 48,667 103 2015

5. b) 1,025,813 919,043 (33,004) (38,790) 992,809 880,253 9,609 14,040 65,173 139,236 1,081,631 1,019,489 203,179 452,912 (33,004) (38,790) 170,175 414,122 17,059 12,868 30,182 10,304 176,949 11,220 394,365 448,514 104

5. c) (i) (ii) 613,733 632,073 377,630 216,750 99,815 28,250 90,859 824 713,548 660,323 468,489 217,574 d) 10% 105 2015

6. 4,313 2,100 4,033 2,740 2,302 10,630 19,730 466 4,800 578 14 22,760 28,946 (17,255) (5,941) (2,573) (1,814) (2,634) (24,276) (5,941) (1,516) 23,005 106

7. a) 14,468 6,813 1,270 60 15,738 6,873 b) 58,974 37,837 7,573 5,663 66,547 43,500 c) 19 17,262 976 691 1,274 894 21 486,771 504,013 13 3,814 1,724 22(c) 145 22(c) (45) 10 40 21 5,355 5,575 139,000 129,000 (2,740) (2,173) 7,415 (i) 19,915,000 107 2015

8. a) 5,600 642 6,201 9,228 30 6,201 9,258 29(b) 134 902 11,935 10,802 i) ii) 16.5% iii) 25% 25% 15% 108

8. b) 51,322 48,667 10,437 10,000 5,234 2,352 (4,509) (282) (2,027) 510 729 263 30 11,935 10,802 c) 258,200,000 221,316,000 12,910,000 11,066,000 109 2015

9. a 1.53 1.28 1.92 1.51 7,968 9,400 7,968 9,400 b) 1.92 1.51 3.86 3.03 9,400 18,862 110

10. a) 31,205 37,865 1,270 60 32,475 37,925 622,500 622,500 * 62,250 2,558 684,750 625,058 * 28 b) 111 2015

11. 383(1) 2 1,142 1,142 956 956 3,046 5 3,051 870 52 922 130 130 148 148 130 130 408 6,014 57 6,479 1,110 26 1,136 924 26 950 829 7 836 758 52 810 140 140 139 139 140 140 419 3,621 111 4,151 112

11. 12 12. 4 4 11 911 760 7 21 918 781 1,000,000 1 1 113 2015

13. 1,368 4,723 7,498 13,589 1 1 12 14 228 1,745 1,973 (175) (175) 1,597 6,294 7,510 15,401 1,597 6,294 7,510 15,401 6 5 211 222 38 2,235 3,807 9,566 815 16,423 2,927 3,145 187 6,259 (413) (10) (112) (535) 3,838 12,620 12,701 8,611 37,770 611 2,927 5,163 8,701 (2) (1) 10 7 218 661 845 1,724 (152) (152) 827 3,435 6,018 10,280 827 3,435 6,018 10,280 7 4 180 191 38 1,557 2,328 4,066 218 8,169 769 1,244 888 913 3,814 (368) (26) (101) (495) 3,160 6,643 4,928 7,228 21,959 678 5,977 7,773 1,383 15,811 770 2,859 1,492 5,121 114

14. 88,810 3,610 92,420 38 3,560 11,900 107,880 a b) c) 86,920,000 27(c)) 115 2015

14. d) (i) 13 107,880 107,880 92,420 92,420 116

14. d) (i) (ii) (i) (ii) 34,653 37,837 4.5% 3.5% 4.5% 6% 2% 5% 100% 100% (i) (ii) 92,420 88,810 38 3,560 11,900 3,610 107,880 92,420 117 2015

14. e 1,575 2,709 1,725 3,300 3,300 6,009 f 15. 75,000,000 75,000,000 75,000,000 118

16. BVI 100% 111 1 100% 195,546,680 100% 1 (b)) 100% 180,900,000 (c)) 55% 2,000,000 119 2015

16. a) BVI b) c) 45% 141,268 132,183 (43,820) (17,533) 212,098 95,444 141,136 17,081 16,860 7,587 143 2,911 (27,420) 120

17. 38 90,693 90,693 90,693 14.83% 3% 42% 121 2015

18. 62,940 45,033 5,000,000 50% 122

18. 54,177 53,185 119,575 81,496 (32,670) (37,708) (15,202) (6,908) 125,880 90,065 3,234 4,454 (4,193) (6,853) (15,202) (6,908) 144,146 152,610 35,815 12,479 35,815 12,479 (268) (233) 26 19 (12,645) (4,180) 125,880 90,065 50% 50% 62,940 45,033 34(b)) 1,730 123 2015

18. 6% 6.5% 6% 2% 5% 100% 70% 80% 124

19. a b 38 104,727 28,700 133,427 104,727 28,700 133,427 12,000 5,262 17,262 12,000 5,262 17,262 92,727 23,438 116,165 (a) (b) 15.83% 16.83% 3% 42% 125 2015

20. (a) 300 (b) 9,309 9,609 (c) 86,296 (a) (b) (i) Sinopharm Healthcare Fund L. P 3.89% 5,000,000 33,930,000 3.89% 1,500,000 10,180,000 Brilliant Appraisal Limited 8,200,000 (ii) Dong Hua Tong Investments Limited 15% Brilliant Appraisal Limited 1,100,000 (c) 3.95% 5.25% 126

21. 3,382 3,370 71,394 70,016 859 79,005 70,016 486,771 502,911 1,102 486,771 504,013 22. (b) (e) 176,184 361,510 (c) (4,726) (4,591) 171,458 356,919 27,271 12,733 45,446 (f) 2,914 2,853 247,089 372,505 23,275 22,548 964 15,812 36(b) 15,782 6,909 287,110 417,774 a) 127 2015

22. b) 0 90 132,703 326,940 91 180 23,094 20,167 181 365 15,412 9,321 1 249 491 171,458 356,919 30 90 32(a) c) 4,591 4,636 7(c)) 145 (10) 7(c)) (45) 4,726 4,591 4,726,000 4,591,000 4,726,000 4,591,000 128

22. d) 132,703 326,940 91 180 23,094 20,167 181 365 15,412 9,321 249 491 38,755 29,979 171,458 356,919 e) 47,116,000 27(c)) 129 2015

22. f) 2,853,000 2,914,000 2,914,000 2,853,000 g) 18,447,000 130

23. 14,040 2,302,000 2.13% 24. 27(c)) 84,097,000 0% 0.35% 3.95% 25. 132,093 199,995 385 183 132,478 200,178 29,850 132,478 230,028 0.01% 0.35% 0.01% 2.9% 131 2015

26. (b)) 116,386 157,172 10,314 4,818 22,087 21,848 148,787 183,838 10,260 2,224 159,047 186,062 a) b) 45 90 0 90 116,386 148,676 91 180 8,496 116,386 157,172 132

27. 1 167,560 228,677 a) b) 4.2% 2.0% - 5.0% c) 14(c)) 86,920 22(e)) 47,116 24 84,097 218,133 167,560,000 133 2015

28. 4,155 10,603 4,155 10,603 4,155 7,277 3,326 133,837,500 105,584,000 Shine Light Investment Fund Legend Times Corporation Limited 105,448,000 7.4% 2.15 62,250,000 13,383,750 10,558,000 134

28. 10,543 94,905 105,448 60 60 10,603 94,905 105,508 1,270 1,270 (8,168) (8,168) 450 450 4,155 94,905 99,060 12.9% 135 2015

29. a) 12,868 10,509 38) 8,002 5,600 642 6,201 9,258 11,801 9,900 (15,612) (7,541) 17,059 12,868 6,452 642 10,607 12,226 b) 9,230 172 9,402 8(a) 902 902 10,132 172 10,304 10,132 172 10,304 38) 20,014 (270) 19,744 8(a) (2,589) 2,723 134 17,425 12,585 172 30,182 c) 8(c) 136

30. 32,047,000 35,252,000 38,777,000 38 3 39 7,177,000 4,604,000 2,573,000 14.59% 14.83% 38 Caretalk Technology Co., Ltd 5,000,000 5,000,000 10,000,000 14,548,000 16,362,000 1,814,000 14.59% 14.83% 137 2015

31. a b d f h i 53,468 152,700 95,863 94,905 (28,147) (21,759) 347,030 (19,123) (19,123) 6,876 6,876 6,876 (19,123) (12,247) 210 210 9(b) (9,400) (9,400) 53,468 152,700 95,863 94,905 (21,271) 210 (50,282) 325,593 53,468 152,700 95,863 (28,984) 5,195 278,242 (8,092) (8,092) 837 837 837 (8,092) (7,255) 94,905 94,905 9(b) (18,862) (18,862) 53,468 152,700 95,863 94,905 (28,147) (21,759) 347,030 138

31. a) 0.1 10,000,000 1,000,000 877,900 0.1 622,500 62,250 53,468 b) c) 10% 50% 25% 139 2015

31. d) e) 2(g) f) 28 2(u) g) 2(e) h) 2(r) i) 2(w)(iv) 140

31. j) i) ii) 198,281,000 226,804,000 1.53 1.28 1.92 1.51 7,968,000 9,400,000 9(a)) k) 167,560 228,677 4,155 10,603 171,715 239,280 (84,097) (132,478) (230,028) 39,237 687,266 570,975 5.71% 0% 141 2015

32. a) i) ii) 30 90 iii) 22% 10% 33% 28% 22 iv) v) vi) 142

32. b) 1 116,386 116,386 116,386 10,314 10,314 10,314 22,087 22,087 22,087 184,909 184,909 167,560 4,411 4,411 4,155 338,107 338,107 320,502 157,172 157,172 157,172 4,818 4,818 4,818 21,848 21,848 21,848 234,832 234,832 228,677 11,893 11,893 10,603 430,563 430,563 423,118 143 2015

32. c) i) % % 4.2 167,560 2.0-5.0 228,677 167,560 228,677 100% 100% 144

32. c) ii) 100 1,218,000 850,000 100 d) 145 2015

32. d) i) 23,794 33 82 77 1,634 32,262 9,742 1,838 1,050 10,000 (89,896) (157,172) (184,677) 33,536 1,871 82 77 2,684 42,262 (89,896) (341,849) 146

32. d) ii) 5% 1,677 (5%) (1,677) 5% (4,491) (5%) 4,491 5% 134 (5%) (134) 5% 94 (5%) (94) 5% (17,089) (5%) 17,089 5% 2,113 (5%) (2,113) 147 2015

32. e) 42% 77% 60 f) 13 148

32. f) 9,309 8,171 1,138 86,296 86,296 14,040 14,040 4,604 4,604 16,362 16,362 149 2015

32. f) 38 7,177 (14,548) 58,900 51,529 10 25,000 25,010 (2,573) (1,814) (4,387) 1,128 2,396 3,524 4,604 (16,362) 1,138 86,296 75,676 150

33. 2 a) b) 151 2015

33. c) d) e) f) g) h) 152

33. i) 90,693,000 17 j) 39 k) 38 153 2015

34. a) 4,394 4,100 2,340 953 6,734 5,053 b) 38 189,367 Sinopharm Healthcare Fund L.P. 3.89% 20 23,800 18 1,730 154

35. 5% 30,000 25,000 7,573,000 5,663,000 36. a) 155 2015

36. b) (i) 2,449 584 (i) 1,618 2,449 2,202 (i) 107 (i) 624 669 624 776 (i) 150 22 (ii) 2,525 2,526 (ii) 13,257 4,383 15,782 6,909 22 (iii) 2,914 2,853 i) ii) iii) 156

36. c) 11 12 7,333 7,037 64 336 7,397 7,373 37. 38. 55% 55% 189,367,000 157 2015

38. 55% 55% 55% 15% 30% 55% 13 8,254 19 133,427 14 3,560 29(b) 270 41,546 58,900 24,977 9,468 (iv) 12,146 (71,724) 29(a) (8,002) 29(b) (20,014) 192,808 45% (86,763) 17 90,693 196,738 189,367 30 14,548 30 (7,177) 196,738 (189,367) 41,546 (147,821) 158

38. (i) 141,136,000 31,753,000 726,477,000 51,674,000 (ii) (iii) 24,977,000 (iv) 12,146,000 (v) 32,047,000 35,252,000 38,777,000 30 39. 159 2015

39. (a) 3,572,000 13,236,000 4 4 300,000 2 6,200,000 3 23,308,000 (b) 2.54 23,308,000 2.54 23,308,000 2.54 2.54 3.2 160

39. (c) 0.770 0.768 0.781 0.782 0.839 0.841 0.768 0.259 0.230 2.450 2.450 2.450 2.450 1.360 2.540 2.540 2.540 2.540 2.540 0.438% 0.657% 0.876% 0.438% 0.606% 63.07% 54.39% 52.13% 63.07% 59.49% 1.89% 2.25% 2.34% 1.89% 2.04% 280% 220% 280% 220% 280% 220% 220% 220% 161 2015

40. 216,957 216,957 122 114 240,477 9,957 69,664 139,122 310,263 149,193 5,234 617 24,678 7,900 167,560 4,155 7,277 201,627 15,794 108,636 133,399 325,593 350,356 3,326 325,593 347,030 53,468 53,468 272,125 293,562 325,593 347,030 162

41. 9 1 15 1 11 2 1 2 16 2 38 16 2 41 27 2 10 2 12 28 10 3 28 2 1 2 3 163 2015

713,548 660,323 554,763 626,840 606,268 51,322 48,667 63,214 61,191 71,353 (11,935) (10,802) (16,037) (12,656) (20,322) 39,387 37,865 47,177 48,535 51,031 31,205 37,865 47,177 48,535 51,031 1,081,631 1,019,489 730,083 640,327 606,651 394,365 448,514 272,659 217,497 212,154 687,266 570,975 457,424 422,830 394,497 164